FDA News Digest
January 14, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
-- Companies Warned About Unsupported Hormone Therapy Claims
-- Fourteen New Tests Licensed for Determining Blood Type
-- 'FDA Patient Safety News' Video, Podcast Available
» Upcoming Public Meetings
» Consumer Health Information
Companies Warned About Unsupported Hormone Therapy Claims
FDA has sent letters warning seven pharmacy operations that claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT," products are unsupported by medical evidence, and that the agency considers these claims to be false and misleading. The pharmacy operations improperly claim that their drugs are superior to FDA-approved menopausal hormone therapy drugs and that they prevent or treat serious diseases, including Alzheimer's disease, stroke, and various forms of cancer.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01772.html Fourteen New Tests Licensed for Determining Blood Type
FDA has licensed 14 new tests for determining blood type, a process essential to a safe 'FDA Patient Safety News' Video, Podcast Available FDA has posted the latest edition of "FDA Patient Safety News," a free Web-based video news program. Aimed primarily at health professionals, the program features information on new drugs, biologics, and medical devices, as well as FDA safety notifications and product recalls. -- To view video or text version: http://www.fda.gov/psn -- To access Podcast: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/podcast.cfm To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
___________________________________________
SAFETY ALERTS/RECALLS
For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml
[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
__________________________________________________________________
UPCOMING PUBLIC MEETINGS
Jan. 23 -- Gastrointestinal Drugs Advisory Committee
Under discussion: pending application for a new post-surgery drug
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-23177.htm
Feb. 1 -- Drug Safety and Risk Management Advisory Committee
Under discussion: pending application for a new drug to treat iron deficiency anemia
Location: Silver Spring, Md.
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-24003.htm
For a complete list of FDA meetings, seminars, and other public events, go to
http://www.fda.gov/opacom/hpmeetings.html.
Here's what's in the spotlight this week:
› Thyroid Medications: Q & A with Mary Parks, M.D. http://www.fda.gov/consumer/features/thyroid010208.html
http://www.fda.gov/consumer/updates/anemia010408.html
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420